ExAblate System for Alzheimer's Disease Treatment

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

Recruiting N/A Interventional Study
Alzheimer Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 85
Sex
Any
Study type
Interventional
Purpose
Device Feasibility
Participants needed
50 (estimated)
Sponsor
InSightec · Industry
Who this trial is looking for

This trial is looking for adults with probable Alzheimer's Disease. If you join, you will undergo a procedure using the ExAblate system to disrupt the blood-brain barrier and help evaluate its safety and effectiveness.

Are You a Good Fit for This Trial?
Rules you out HIVChronic pulmonary disordersKnown apolipoprotein E allele (ApoE4) homozygosity

You may be able to join if

  • I am between 50 and 85 years old
  • I have probable Alzheimer's Disease
  • I can communicate during the procedure
  • I am able to walk independently
  • I have been taking my Alzheimer's medication for at least 2 months
  • I have been on a stable dose of my Alzheimer's medication for at least 3 months

You may not be able to join if

  • I have significant heart disease
  • I have a history of seizures or epilepsy
  • I have untreated, uncontrolled sleep apnea
  • I have a history of liver disease
  • I have major depression and may be at risk of suicide
  • I have a bleeding disorder
  • I have significant problems with my kidneys
  • I have known serious blood vessel problems in my brain or body

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Male or Female between 50-85 years of age 2. Probable Alzheimer's Disease (AD) 3. If taking concurrent Alzheimer's medication, has been on the medication for at least 2 months with a stable dose for at least 3 months 4. Able to communicate sensations during the ExAblate MRgFU…
Contacts

No contact information available.